
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.00 GBP
4.50 M GBP
787.60 M GBP
559.74 M
About Dr. Martens Plc
Sector
Industry
CEO
Ije Nwokorie
Website
Headquarters
London
Founded
1945
ISIN
GB00BL6NGV24
FIGI
BBG00YTZSCF3
Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm offers boots, shoes, sandals, shoe care products, laces, and socks. It operates through the following geographical segments: EMEA, Americas, and APAC. The company was founded by Klaus Maertens in 1945 and is headquartered in London, the United Kingdom.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where DOCS is featured.
Frequently Asked Questions
The current price of DOCS is 92.40 GBX — it has increased by 1.55% in the past 24 hours. Watch Dr. Martens Plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange Dr. Martens Plc stocks are traded under the ticker DOCS.
DOCS stock has risen by 5.93% compared to the previous week, the month change is a 26.46% rise, over the last year Dr. Martens Plc has showed a 46.67% increase.
We've gathered analysts' opinions on Dr. Martens Plc future price: according to them, DOCS price has a max estimate of 141.00 GBX and a min estimate of 75.00 GBX. Watch DOCS chart and read a more detailed Dr. Martens Plc stock forecast: see what analysts think of Dr. Martens Plc and suggest that you do with its stocks.
DOCS reached its all-time high on Feb 9, 2021 with the price of 521.60 GBX, and its all-time low was 43.00 GBX and was reached on Apr 7, 2025. View more price dynamics on DOCS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DOCS stock is 7.16% volatile and has beta coefficient of 1.81. Track Dr. Martens Plc stock price on the chart and check out the list of the most volatile stocks — is Dr. Martens Plc there?
Today Dr. Martens Plc has the market capitalization of 888.38 M, it has decreased by −0.93% over the last week.
Yes, you can track Dr. Martens Plc financials in yearly and quarterly reports right on TradingView.
Dr. Martens Plc is going to release the next earnings report on Nov 27, 2025. Keep track of upcoming events with our Earnings Calendar.
DOCS earnings for the last half-year are 0.04 GBX per share, whereas the estimation was 0.03 GBX, resulting in a 17.65% surprise. The estimated earnings for the next half-year are −0.01 GBX per share. See more details about Dr. Martens Plc earnings.
Dr. Martens Plc revenue for the last half-year amounts to 463.00 M GBX, despite the estimated figure of 472.73 M GBX. In the next half-year revenue is expected to reach 331.77 M GBX.
DOCS net income for the last half-year is 25.30 M GBP, while the previous report showed −20.80 M GBP of net income which accounts for 221.63% change. Track more Dr. Martens Plc financial stats to get the full picture.
Dr. Martens Plc dividend yield was 5.00% in 2024, and payout ratio reached 542.55%. The year before the numbers were 2.91% and 36.22% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 15, 2025, the company has 2.35 K employees. See our rating of the largest employees — is Dr. Martens Plc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Dr. Martens Plc EBITDA is 133.30 M GBP, and current EBITDA margin is 16.92%. See more stats in Dr. Martens Plc financial statements.
Like other stocks, DOCS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Dr. Martens Plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Dr. Martens Plc technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Dr. Martens Plc stock shows the neutral signal. See more of Dr. Martens Plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.